Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of oral lorazepam liquid in pediatric ICU patients
NL-OMON44702Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lorazepam in sedative use disorder (SUD) and substance withdrawal, sponsored by Erasmus MC. Primary endpoint: Pharmacokinetic parameters of lorazepam. Started Dec 2015; status: active, not recruiting.
02
Drugs
lorazepam
03
Conditions
sedative use disorder (SUD)substance withdrawal
Beyond the preview
Go deeper on NL-OMON44702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44702.